Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series

Kaohsiung Journal of Medical Sciences

Volumn 35, Issue 9, 2019, Pages 566-571

  Wang, Jiunn Wei ^a   Wang, Yao Kuang ^a   Zhang, Faming ^b   Su, Yu Chung ^a,c   Wang, Jaw Yuan ^a,c   Wu, Deng Chyang ^a,c,d   Hsu, Wen Hung ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Clostridium difficile infection; fecal microbiota transplantation; inflammatory bowel disease; transendoscopic enteral tubing

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; FIDAXOMICIN; HEMOGLOBIN; METRONIDAZOLE; PREDNISOLONE; PROBIOTIC AGENT; STEROID; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DECUBITUS; DIARRHEA; DISEASE COURSE; DIZZINESS; DONOR SELECTION; DRUG DOSE ESCALATION; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON THERAPY; MALE; PANCOLITIS; PNEUMONIA; RECTUM HEMORRHAGE; REMISSION; RETROSPECTIVE STUDY; SALVAGE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VERY ELDERLY; DIAGNOSTIC IMAGING; DONOR;

ADULT; AGED, 80 AND OVER; COLONOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; TISSUE DONORS;

EID: 85067358355     PISSN: 1607551X     EISSN: 24108650     Source Type: Journal    
DOI: 10.1002/kjm2.12094     Document Type: Article

References (20)

1. Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol. 2015;21:102–111.
2. Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145:946–953.
3. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044–1049.
4. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–415.
5. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.
6. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:761–767.
7. Satokari R, Mattila E, Kainulainen V, Arkkila PE. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection—An observational cohort study. Aliment Pharmacol Ther. 2014;41:46–53.
8. Anderson JL, Edney RJ, Whelan K. Systematic review: Faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:503–516.
9. Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, et al. Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota. Endosc Int Open. 2016;4:E610–E613.
10. Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: A review and pooled analysis. Infection. 2012;40:643–648.
11. Ianiro G, Masucci L, Quaranta G, Simonelli C, Lopetuso LR, Sanguinetti M, et al. Randomised clinical trial: Faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018;48:152–159.
12. Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol. 2014;20:14805–14820.
13. Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: Adverse events of fecal microbiota transplantation. PLoS One. 2016;11:e0161174.
14. Schwan A, Sjolin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet. 1983;2:845.
15. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079–1087.
16. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989;1:164.
17. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol. 2003;37:42–47.
18. Narula N, Kassam Z, Yuan Y, Colombel JF, Ponsioen C, Reinisch W, et al. Systematic review and meta-analysis: Fecal microbiota transplantation for treatment of active ulcerative colitis. Inflamm Bowel Dis. 2017;23:1702–1709.
19. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102–9 e6.
20. Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial. Lancet. 2017;389:1218–1228.